Autophagy modulation in gynaecologic oncology: insights into immune regulation and therapeutic potential - Summary - MDSpire

Autophagy modulation in gynaecologic oncology: insights into immune regulation and therapeutic potential

  • By

  • Mingyu Huang

  • Defeng Zhao

  • Rui Xiong

  • Ruimin Yuan

  • Yumeng Lin

  • Yi Wang

  • Caijun Xiong

  • Lan Yuan

  • Zhongyu Han

  • Haoran Chen

  • June 15, 2026

  • 0 min

Share

Objective:

To evaluate the role of autophagy in gynecologic cancers, focusing on its impact on immune response and treatment resistance.

Approach:
    Key Findings:
    • Autophagy regulates immune checkpoint expression (e.g., PD-L1 and MHC-I).
    • It shapes antitumor immunity through T cells, macrophages, and other immune components.
    • Autophagy modulates drug resistance via pathways involving AMPK, HSF1, and ROS.
    Interpretation:

    Remove unsupported conclusions about autophagy's role in cancer.

    Limitations:
    • Unresolved pathological mechanisms related to autophagy in gynecologic cancers.
    • Translational gaps in applying autophagy research to clinical practice.
    Conclusion:

    Revise to avoid implications about precision medicine approaches unless directly supported.

Original Source(s)

Autophagy modulation in gynaecologic oncology: insights into immune regulation and therapeutic potential

  • by Mingyu Huang, Defeng Zhao, Rui Xiong, Ruimin Yuan, Yumeng Lin, Yi Wang, Caijun Xiong, Lan Yuan, Zhongyu Han, Haoran Chen

  • June 15, 2026

Related Content

Editorial: Innate lymphoid cells in cancer: volume II

Is leptomeningeal dissemination in oligodendroglioma predictable? Evidence from a scoping review

Radiomic analysis of the peritumoral zone identifies imaging signatures of glioma invasion associated with HSP70 expression